EIT Health Bridgehead 2021
EIT Health’s Bridgehead brings together European health entrepreneurs who want to grow their business beyond their home market.
EIT Health will help match your scale-up with an incubator or accelerator from EIT Health’s approved network – organisations called 'Catalysers'. Together, you will plan how to access new markets quickly and decisively, tap into local networks of partners and clients, access infrastructure and understand new regulatory systems.
The programme is split into:
- Bridgehead Europe
- Bridgehead Global
Both programmes are similar in structure but differ in organisation. Bridgehead Europe aims to help start-ups expand their business beyond their home market into a different European country, and Bridgehead Global aims at internationalisation beyond Europe. Depending on their internalisation needs, start-ups can apply to either one or another in a given year. Whichever programme you successfully apply for, you will be given the seasoned expertise, insight and support needed to help realise your business ambitions.
Who should apply?
To qualify for Bridgehead Europe or Global, your company must:
- Be registered in Europe
- Sell a product or services in at least one market in Europe and be ready to open up a new market
- Deliver innovative, transformative products or services in biotech, medtech or digital health
- Have fewer than 250 full time employees
Want to find out more?
Join one of EIT Health's Bridgehead webinars to learn more about the programme and find out if it is right for you. There are two webinars during the registration period, and all you need to do is register below to secure your place:
- 10 February 2021 at 11:00 AM (CET) - Register here
- 03 March 2021 at 11:00 AM (CET) - Register here
See the Bridgehead call document for more detailed information on the programme. This document explains, for example, that you can apply to both Bridgehead Europe and Global, but you can only participate and be chosen for one.
Submit an application through EIT Health's portal by 16 March 2021
Share this page
